Data from competitive protein–protein interaction and immunoprecipitation assays showed that BT44 augmented the anti-tumor activity of etoposide by dissociating the Hsp70–Caspase-3 complex (Figure 6A,B). The gene discussed is CASP3; the disease is neoplasm.